Deucravacitinib Rosacea

NCT06532136 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This study is being closed due to sponsor withdrawal of funding and support.

Conditions

Papulopustular Rosacea

Interventions

DRUG: Deucravacitinib
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]